Targeting AXL in NSCLC

Overview of attention for article published in Lung Cancer: Targets and Therapy, August 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

reddit: 1 Redditor

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Recent discovery and development of AXL inhibitors as antitumor agents

Article in European Journal of Medicinal Chemistry (May 2024)

Anticancer potential of grifolin in lung cancer treatment through PI3K/AKT pathway inhibition

Article in Heliyon (April 2024)

Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer

Article in Acta Pharmacologica Sinica (March 2024)